Navigation Links
Antidepressants Help HIV-Infected Patients Stick to Treatment
Date:1/4/2008

Depression can cause many to skip their medicines, experts note

FRIDAY, Jan. 4 (HealthDay News) -- People with HIV who suffer from depression are much less likely to stick with their treatment regimens, new research shows.

However, treating their depression with widely used selective serotonin reuptake inhibitor (SSRI) antidepressants can get them back on track, the researchers said.

A team from Kaiser Permanente in Oakland, Calif., analyzed the mental health, disease progression and treatment data of almost 3,400 HIV-infected patients nationwide between 2000 and 2003. All patients were starting a new, highly active antiretroviral therapy (HAART).

Reporting in the current online issue of the Journal of Acquired Immune Deficiency Syndromes, they found that almost half of the study participants (42 percent) had depression during the 12-month study. Those who were depressed were less likely to take their medications and had worse viral response than people who were not depressed. However, when depressed people took prescribed SSRIs -- which include drugs such as Celexa, Paxil, Prozac and Zoloft -- they had the same health outcomes as patients who were not depressed.

"The take-home point of this study is that depression carries a worse prognosis for HAART in HIV patients. However, we also found that SSRIs can reverse this and improve outcomes for HIV-depressed patients," lead author Dr. Michael A. Horberg, director of HIV/AIDS for Kaiser Permanente, said in a prepared statement. "HIV and depression often go hand in hand. If you are HIV-infected, you should be screened regularly for depression, and if you are depressed, and you are going to go on HAART, it's very worthwhile to treat your depression."

More information

To learn more about depression, visit the American Academ
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Study shows new strategy for developing antidepressants
2. Antidepressants Boost GI Bleeding Risk
3. Antidepressants and painkillers - a dangerous combination
4. Newer antidepressants led to less, not more, teen suicides
5. Experimental Antidepressants Offer Faster Relief
6. Newly HIV-Infected Gay Men Select Other Infected Partners
7. Striking shift seen among newly HIV-infected men regarding partners
8. One-Third of HIV-Infected Gay Men Have Unsafe Sex: CDC
9. Pneumococcal conjugate vaccines can improve the lives of HIV-infected children
10. JAMA study shows what works in treating HIV-infected African children
11. Exercise program improves symptoms in arthritis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 2015 , ... The New Jersey Innovation Institute (NJII), acting ... Health, has received a $2.9 million grant from the Office of the National ... and Human Services (HHS). NJII will help the Department of Health ensure the ...
(Date:7/30/2015)... ... July 30, 2015 , ... InventHelp, a leading inventor service ... personal-care device that makes it easy to apply lotion or medication to a hard-to-reach ... assistance when applying lotion or medication to the back, and provides thorough coverage. The ...
(Date:7/30/2015)... ORLEANS (PRWEB) , ... July 30, 2015 , ... Author ... and take charge of their health in his new self-help book, “ Consciously Healing ... Llanos’ new book promotes a simple message: “If we take responsibility for ourselves, we ...
(Date:7/30/2015)... ... , ... Summer is the dry eye season, especially in parts of the ... and hot 2015 summer season and the dry eye rate in the hot spots ... the 2015 summer season and identify the primary dry eye hot spots on her ...
(Date:7/30/2015)... ... July 30, 2015 , ... HEALTHCAREfirst , the leading ... announced today that it is hosting a free webinar detailing the 2016 proposed rule ... HEALTHCAREfirst Consultant and former Vice President of Regulatory Affairs for the National Association for ...
Breaking Medicine News(10 mins):Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 2Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 3Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2
... , NEW YORK, Dec. 10 SIRIUS ... Doctor Radio Reports: Kids and Video Games - What ... by journalist Perri Peltz on which she and a panel of experts ... effects they have on children. , (Logo: http://www.newscom.com/cgi-bin/prnh/20080819/NYTU044LOGO ) , ...
... , SALEM, Ore., Dec. 10 West Coast Bank,s ... Bears for children hospitalized at the Salem Hospital Pediatric Wing and ... Bears at the branch, 5686 Commercial St. SE, Suite 110 on ... BSN CPN, Nurse Manager of Pediatrics at Salem Hospital said, "The ...
... of alcoholic beverages (at least three to four drinks per ... a 30 percent increased risk of breast cancer recurrence, according ... may be most susceptible to the effects of alcohol on ... of this study will be presented December 9-13 at the ...
... to die or be disabled by midlife, study finds, , THURSDAY, ... a man,s risk of dying or becoming disabled by the time ... findings are from a study that began following 411 South London ... those who at age 10 displayed antisocial behavior (such as skipping ...
... ... leader in Sales and Operations Planning (S&OP) solutions, announced a program ... JDA The Steelwedge "i2 Exchange Program" address i2 customers that ... recently announced merger between i2 and JDA (formerly Manugistics), or are ...
... , RANCHO CORDOVA, Calif., Dec. 10 ThermoGenesis Corp. (Nasdaq: ... processing and storing adult stem cells, said today that Craig ... industry experience, has been named to the Company,s board of ... to six. , Moore is currently associated with several public ...
Cached Medicine News:Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: Kids and Video Games - What You Should Know Before You Buy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: Kids and Video Games - What You Should Know Before You Buy' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: Kids and Video Games - What You Should Know Before You Buy' 4Health News:Alcohol consumption may increase breast cancer recurrence risk 2Health News:Bad Behavior as a Kid Linked to Early Death in Men 2Health News:Leading Sales and Operations Planning (S&OP) Provider Steelwedge Announces i2 Exchange Program 2Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 2Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 3Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 4
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... , July 30, 2015  Medimetriks Pharmaceuticals, ... the second Phase III clinical study for Ozenoxacin, ... impetigo.  Medimetriks owns the exclusive U.S. rights to ... trial, conducted at 44 centers with an emphasis ... patients aged 2 months and older with a ...
(Date:7/30/2015)... Global ENT (Ear, Nose, ... USD 23.01 million in 2022, according to a new ... geriatric population, increasing prevalence of ear, nose, and throat ... among target customer base are expected serve this market ... According to estimates published by the WHO, 15% of ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
... the World,s First Generic Pirfenidone in India, Giving Hope to... -- MUMBAI, India, October 20, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...
... Va., Oct. 20 Medmarc Insurance , ... medical device and life sciences industry, launched today the ... visitors to its website with leading industry product and ... the Network is available to everyone that visits ...
Cached Medicine Technology:Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 2Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 3Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 4Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 5Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 6Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 7Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 8Medmarc Business Network Launched - Saving Medical Device and Life Sciences Manufacturers Time & Money 2
Inquire...
Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
... and Hypergamma Controls are designed ... agarose gels or Sebia's ... unique control manufacturing process preserves ... other serum components, presenting a ...
The HYRYS™ 2 densitometer is reflective of Sebia's expertise in the development and design of imaging systems and densitometers utilized in the electrophoresis field....
Medicine Products: